Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1127studies shown
Showing 1-25 of 1,127
Active Not RecruitingNCT06809595

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

This study is active but not recruiting. It focuses on anxiety and currently lists study information in Czech Republic, France, Germany, Poland, the United Kingdom, and the United States.

AnxietyOtherFrom 18 Years to 74 Years
Countries
Czech Republic, France, Germany, Poland, United Kingdom, United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Anxiety
Not Yet RecruitingNCT07189689

Mental Health Mission Mood Disorder Cohort Study

This study is not yet recruiting. It focuses on depression and currently lists study information in the United Kingdom.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
RecruitingNCT05973786

The Effect of a Six Week Intensified Pharmacological Treatment for Depression in bipolarity Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

This study is recruiting. It focuses on depression and currently lists participation information in Austria, Germany, Greece, Italy, Spain, and the United Kingdom.

DepressionOtherOver 18 Years
Countries
Austria, Germany, Greece, Italy, Spain, United Kingdom
Sponsor
Dr. Inge Winter
Condition
Depression
RecruitingNCT06412315

7T Amygdala and Citalopram Study

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionDrugFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
CompletedNCT05841030

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed. It focuses on depression and currently lists study information in Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study has public registry information. It focuses on depression and currently lists study information in Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, the United States, South Korea, Spain, Taiwan, and the United Kingdom.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT06793397

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Czech Republic, Germany, Greece, Ireland, Poland, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
RecruitingNCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

This study is recruiting. It focuses on depression and currently lists participation information in Bulgaria, Czech Republic, Poland, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Czech Republic, Poland, United Kingdom, United States
Sponsor
Draig Therapeutics Ltd
Condition
Depression
RecruitingNCT05549102

CBT and the Neural Circuits of Anxiety

This study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.

AnxietyBehavioralFrom 18 Years to 64 Years
Countries
United Kingdom
Sponsor
UCLH/UCL Joint Research Office
Condition
Anxiety
RecruitingNCT06806176

Effectiveness of CAT-GSH for Returning Patients

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionBehavioralOver 16 Years
Countries
United Kingdom
Sponsor
University of Sheffield
Condition
Depression
Active Not RecruitingNCT05711940

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

This study is active but not recruiting. It focuses on depression and currently lists study information in Canada, Czech Republic, Denmark, France, Germany, Ireland, the Netherlands, Poland, Spain, Sweden, the United Kingdom, and the United States.

DepressionOtherOver 18 Years
Countries
Canada, Czech Republic, Denmark, France, Germany, Ireland, Netherlands, Poland, Spain, Sweden, United Kingdom, United States
Sponsor
COMPASS Pathways
Condition
Depression
United Kingdom | Clinical Trials | HopeStage Research